Erin Cloke
Psychiatric/Mental Health · Austin, TXNPI 1104549518
Payments from drug & device makers
Across 462 payments — averaging $20.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Alkermes, Inc.$877
- Johnson & Johnson$579
- Bausch Health US, LLC$556
- plus $4K from 19 others
What the payments were for
- Food & beverage$9,563100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 87 | $1,738 |
| Otsuka America Pharmaceutical, Inc. | 54 | $1,077 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 56 | $1,070 |
| Alkermes, Inc. | 47 | $877 |
| Johnson & Johnson | 18 | $579 |
| Bausch Health US, LLC | 28 | $556 |
| Lundbeck LLC | 21 | $479 |
| Axsome Therapeutics, Inc. | 16 | $422 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $413 |
| Corium, LLC | 23 | $400 |
| Vanda Pharmaceuticals Inc. | 17 | $353 |
| Neurocrine Biosciences, Inc. | 16 | $347 |
| Teva Pharmaceuticals USA, Inc. | 16 | $342 |
| Supernus Pharmaceuticals, Inc. | 13 | $188 |
| Idorsia Pharmaceuticals US Inc | 7 | $143 |
| Noven Therapeutics, LLC | 6 | $125 |
| Tris Pharma Inc | 1 | $120 |
| Lilly USA, LLC | 2 | $111 |
| E.r. Squibb & Sons, L.L.C. | 3 | $73 |
| Ironshore Pharmaceuticals Inc. | 2 | $42 |
| TMS Neurohealth Centers Inc. | 2 | $35 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Noven Pharmaceuticals, Inc. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Acadia Pharmaceuticals Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$411
- VRAYLAR$348
- SPRAVATO$238
- Azstarys$125
- REXULTI$125
- Quillichew ER$120
- Dyanavel XR$120
- Quillivant$120
How this compares
$9,564 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 14 | $703 |
| Bupropion XlBupropion Hcl | 18 | $310 |
| Gabapentin | 16 | $237 |
| Escitalopram Oxalate | 18 | $128 |
| Zolpidem Tartrate | 14 | $50 |
| Fluoxetine Hcl | 13 | $32 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Austin
- Jaime Nelson DensonAustin$88K
- Camille WatsonAustin$34K
- Suzanne GranthamAustin$31K
- Lin CaiAustin$16K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.